These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17502119)

  • 1. ATM missense variant P1054R predisposes to prostate cancer.
    Meyer A; Wilhelm B; Dörk T; Bremer M; Baumann R; Karstens JH; Machtens S
    Radiother Oncol; 2007 Jun; 83(3):283-8. PubMed ID: 17502119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer.
    Cesaretti JA; Stock RG; Lehrer S; Atencio DA; Bernstein JL; Stone NN; Wallenstein S; Green S; Loeb K; Kollmeier M; Smith M; Rosenstein BS
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):196-202. PubMed ID: 15629612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy.
    Cesaretti JA; Stock RG; Atencio DP; Peters SA; Peters CA; Burri RJ; Stone NN; Rosenstein BS
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1410-6. PubMed ID: 17490827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of cancer by ATM missense mutations in the general population.
    Dombernowsky SL; Weischer M; Allin KH; Bojesen SE; Tybjaerg-Hansen A; Nordestgaard BG
    J Clin Oncol; 2008 Jun; 26(18):3057-62. PubMed ID: 18565893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer in female carriers of ATM gene alterations: outcome of adjuvant radiotherapy.
    Meyer A; John E; Dörk T; Sohn C; Karstens JH; Bremer M
    Radiother Oncol; 2004 Sep; 72(3):319-23. PubMed ID: 15450731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological features of breast cancer in carriers of ATM gene variants.
    Balleine RL; Murali R; Bilous AM; Farshid G; Waring P; Provan P; Byth K; Thorne H; ; Kirk JA
    Histopathology; 2006 Nov; 49(5):523-32. PubMed ID: 17064299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
    Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D
    Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of mutations in ATM to breast cancer development in the Czech population.
    Soukupova J; Dundr P; Kleibl Z; Pohlreich P
    Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.
    Dörk T; Bendix R; Bremer M; Rades D; Klöpper K; Nicke M; Skawran B; Hector A; Yamini P; Steinmann D; Weise S; Stuhrmann M; Karstens JH
    Cancer Res; 2001 Oct; 61(20):7608-15. PubMed ID: 11606401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of ATM missense variants and their contribution to contralateral breast cancer.
    Broeks A; Braaf LM; Huseinovic A; Schmidt MK; Russell NS; van Leeuwen FE; Hogervorst FB; Van 't Veer LJ
    Breast Cancer Res Treat; 2008 Jan; 107(2):243-8. PubMed ID: 17393301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
    Lehrer S; Cesaretti J; Stone NN; Stock RG
    BJU Int; 2006 Nov; 98(5):979-81. PubMed ID: 17034599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATM polymorphism IVS62+60G>A is not associated with disease aggressiveness in prostate cancer.
    Browning RE; Li H; Shinohara ET; Cai Q; Chen H; Courtney R; Cao C; Zheng W; Lu B
    Urology; 2006 Jun; 67(6):1320-3. PubMed ID: 16765197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations.
    Brunet J; Gutiérrez-Enríquez S; Torres A; Bérez V; Sanjosé S; Galceran J; Izquierdo A; Menéndez JA; Gumà J; Borràs J
    Clin Genet; 2008 May; 73(5):465-73. PubMed ID: 18384426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atm-haploinsufficiency enhances susceptibility to carcinogen-induced mammary tumors.
    Lu S; Shen K; Wang Y; Santner SJ; Chen J; Brooks SC; Wang YA
    Carcinogenesis; 2006 Apr; 27(4):848-55. PubMed ID: 16400190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two ATM variants and breast cancer risk.
    Thompson D; Antoniou AC; Jenkins M; Marsh A; Chen X; Wayne T; Tesoriero A; Milne R; Spurdle A; Thorstenson Y; Southey M; Giles GG; Khanna KK; Sambrook J; Oefner P; Goldgar D; Hopper JL; Easton D; Chenevix-Trench G;
    Hum Mutat; 2005 Jun; 25(6):594-5. PubMed ID: 15880680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between genetic variants of the ataxia telangiectasia-mutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia.
    Meier M; den Boer ML; Hall AG; Irving JA; Passier M; Minto L; van Wering ER; Janka-Schaub GE; Pieters R
    Leukemia; 2005 Nov; 19(11):1887-95. PubMed ID: 16167060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer.
    Spring K; Ahangari F; Scott SP; Waring P; Purdie DM; Chen PC; Hourigan K; Ramsay J; McKinnon PJ; Swift M; Lavin MF
    Nat Genet; 2002 Sep; 32(1):185-90. PubMed ID: 12195425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATM variants and cancer risk in breast cancer patients from Southern Finland.
    Tommiska J; Jansen L; Kilpivaara O; Edvardsen H; Kristensen V; Tamminen A; Aittomäki K; Blomqvist C; Børresen-Dale AL; Nevanlinna H
    BMC Cancer; 2006 Aug; 6():209. PubMed ID: 16914028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of ATM gene mutations in young lung cancer patients: a population-based control study.
    Schneider J; Illig T; Rosenberger A; Bickeböller H; Wichmann HE
    Arch Med Res; 2008 Feb; 39(2):226-31. PubMed ID: 18164969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATM and breast cancer susceptibility.
    Ahmed M; Rahman N
    Oncogene; 2006 Sep; 25(43):5906-11. PubMed ID: 16998505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.